Moody National Bank Trust Division decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,966 shares of the pharmacy operator’s stock after selling 25 shares during the quarter. Moody National Bank Trust Division’s holdings in Walgreens Boots Alliance were worth $781,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Reilly Financial Advisors LLC grew its position in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares in the last quarter. Hudock Capital Group LLC grew its position in Walgreens Boots Alliance by 0.4% during the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 5 shares in the last quarter. Tarbox Group Inc. grew its position in Walgreens Boots Alliance by 288.3% during the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after purchasing an additional 1,006 shares in the last quarter. Webster Bank N. A. grew its position in Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after purchasing an additional 235 shares in the last quarter. Finally, Orrstown Financial Services Inc. grew its position in Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares in the last quarter. Hedge funds and other institutional investors own 60.18% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/16/moody-national-bank-trust-division-sells-25-shares-of-walgreens-boots-alliance-inc-wba.html.

WBA has been the topic of several research analyst reports. Morgan Stanley reiterated an “overweight” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Loop Capital initiated coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a “buy” rating and a $95.00 price objective on the stock. Finally, Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $91.81.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 82.50 on Friday. The firm has a market cap of $88.28 billion, a price-to-earnings ratio of 20.83 and a beta of 1.26. The company has a 50 day moving average of $81.26 and a 200 day moving average of $81.99. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same quarter in the prior year, the firm earned $1.18 earnings per share. The firm’s revenue was up 2.1% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.94%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 40.30%.

Walgreens Boots Alliance declared that its board has authorized a share repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 13.50% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.